Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Glucose Metabolism Disorders » Hyperglycemia
Description
Abnormally high BLOOD GLUCOSE level. MeSH
Hierarchy View
Subtype Terms (1)
Glucose Intolerance
109 drugs (56 approved, 53 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (38)
Phase 2 Indicated Drugs (7)
Phase 1 Indicated Drugs (10)
Other Experimental Indicated Drugs (64)
Organization Involved with Phase 4 Indications (65)
Birjand University of Medical Sciences
Canterbury District Health Board
Genovate Biotechnology Co., Ltd.,
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
LMC Diabetes & Endocrinology Ltd.
Medical University of South Carolina
National Health and Medical Research Council, Australia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of General Medical Sciences (NIGMS)
Taipei Veteran General hospital
The Baruch Padeh Medical Center, Poriya
The First People's Hospital of Lianyungang
Organization Involved with Phase 3 Indications (34)
Canadian Institutes of Health Research (CIHR)
Hospital Regional Alta Especialidad Bajio
National Cancer Institute (NCI)
National Institute of Neurological Disorders and Stroke (NINDS)
Neurological Emergencies Treatment Trials Network
Organization Involved with Phase 2 Indications (26)
Organization Involved with Phase 1 Indications (14)
Organization Involved with Other Experimental Indications (81)
Alliance for Potato Research and Education
Case Western Reserve University
District of Columbia Department of Health
Huazhong University of Science and Technology
Moorgreen Hospital, Southampton
National Center for Research Resources (NCRR)
National University of Singapore
Oklahoma Center for the Advancement of Science and Technology
Pennington Biomedical Research Center
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Singapore Institute for Clinical Sciences
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
